Atlas Venture Fund XII, L.P. 13D/13G Filings for Jade Biosciences, Inc. (JBIO)

Atlas Venture Fund XII, L.P. 13D and 13G filings for Jade Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-30
4:29 pm
Purchase
2025-04-2813DJade Biosciences, Inc.
JBIO
Atlas Venture Fund XII, L.P. 51,406
0.200%
51,406increase
(New Position)
Filing